CD4+ T-cell receptor (TCR)

CD4+ T-cell receptors (TCRs) are membrane-bound heterodimeric proteins found on the surface of helper T cells that play a central role in the adaptive immune system. These receptors specifically recognize antigenic peptides presented by Major Histocompatibility Complex (MHC) Class II molecules on antigen-presenting cells (Janeway's Immunobiology). Promiscuous helper epitopes are unique peptide sequences capable of binding to a wide range of MHC Class II alleles, ensuring broad population coverage for immune recognition (Alexander et al., 1994). When a TCR binds to such an epitope, it triggers a signaling cascade that activates the CD4+ T cell, leading to the production of cytokines that orchestrate the activity of other immune cells, including B cells and cytotoxic CD8+ T cells (Kaumaya et al., 1993). In therapeutic contexts, these TCRs are targeted via peptide vaccines or engineered TCR-T cell therapies to enhance anti-tumor or anti-viral immunity (Slingluff, 2011). Understanding the interaction between TCRs and promiscuous epitopes is crucial for developing universal vaccines and immunotherapies that are effective across diverse genetic backgrounds. Furthermore, these receptors are involved in the immunogenicity of biotherapeutics, where they recognize drug-derived peptides and initiate the formation of anti-drug antibodies (Tourdot, 2025). Therapeutic manipulation of these receptors must be carefully managed to avoid over-activation, which can lead to cytokine release syndrome or autoimmune pathology.

Other names

T-cell receptorCD4 TCRMHC Class II-restricted T-cell receptorAlpha-beta T-cell receptorHelper T-cell receptorTCR recognizing promiscuous helper epitope

Activation of CD4+ helper T cells through the recognition of peptide-MHC class II complexes, leading to the secretion of cytokines (e.g., IL-2, IFN-gamma) that support B-cell maturation and CD8+ T-cell effector function.